Company Name
Seedling Bio
Year of Establishment
2021
Annual Turnover(USD)
500,000 to 99,999,999
Company Introduction
We take the advantages of synthetic biotechnology as its core competitiveness, and is committed to continuously improving the quality of life, prolonging the length of life, and bringing a healthier and more beautiful life experience to human beings.
Seedling Bio is determined to become a technology leader in the domestic synthetic biology industry, and use synthetic biology technology to better serve the nutrition and health industry.
Main Competitive Advantages
Brand Name,Experienced R&D Staff,Delivery Term,Production Capacity,Small Orders Accepted,Quality Service,
Other Competitive Advantages
Having own laboratory to provide testing data and support
Patents and Copyright
Patent Name: A method for constructing a genetically engineered bacterium producing ectoine and its application Patent Number: 2024116166104